Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last SFr.112.60 CHF
Change Today -2.40 / -2.09%
Volume 518.3K
As of 11:43 AM 03/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Martine Clozel

Chief Scientific Officer, Senior Vice President and Member of the Management Board, Actelion Ltd.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

59--

Background*

Mr. Martine Clozel founded Actelion Pharmaceuticals U.S., Inc. in 1997 and serves as its Chief Scientific Officer, Senior Vice President and Head of Drug Discovery Pharmacology & Preclinical Development. Ms. Clozel has been Senior Vice President of Actelion Ltd. since 1997 and serves as its Member of the Management Board. She has been Chief Scientific Officer of Actelion Ltd., since April 2009 and served as its Head of Drug Discovery Pharmacologa & Preclinical Development. ...

Read Full Background

Corporate Headquarters*

Gewerberstrasse 16
Allschwil, Basel-Landschaft 4123

Switzerland

Phone: 41 61 565 65 65
Fax: 41 61 565 65 00

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Unknown/Other Education
University of California-San Francisco
Unknown/Other Education
McGill University
Unknown/Other Education
Université Nancy 2

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATLN:VX SFr.112.60 CHF -2.40

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marc M.P. de Garidel Chairman, Chief Executive Officer and Member of Strategic Committee
Ipsen S.A.
€1.4M
Giovanni Recordati Chairman, Chief Executive Officer and General Manager
Recordati SpA
€1.4M
Jean-Christophe Tellier Chief Executive Officer and Executive Director
UCB S.A.
--
Jörg-Thomas Dierks Chief Executive Officer
Meda AB
kr2.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACTELION LTD-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.